Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Reducing Tobacco Smoking: a Transcranial Direct Current Stimulation (TDCS) Telehealth Study

NCT: NCT05460676 · COMPLETED

NCT IDNCT05460676
StatusCOMPLETED
Start Date2023-08-15
Completion2026-01-22

Brief Summary

The study aims to evaluate the feasibility of using Dorsolateral Prefrontal Cortex (DLPFC) Transcranial Direct Current Stimulation (tDCS) as a tool to decreasing distress and cigarette smoking. 46 participants currently smoking cigarettes, and seeking to decrease cigarette use will be recruited.

Frequently Asked Questions

What is Reducing Tobacco Smoking: a Transcranial Direct Current Stimulation (TDCS) Telehealth Study?

Reducing Tobacco Smoking: a Transcranial Direct Current Stimulation (TDCS) Telehealth Study is a clinical trial registered under NCT05460676. Current status: COMPLETED.

What is the status of NCT05460676?

The current status of NCT05460676 (Reducing Tobacco Smoking: a Transcranial Direct Current Stimulation (TDCS) Telehealth Study) is: COMPLETED.

When did Reducing Tobacco Smoking: a Transcranial Direct Current Stimulation (TDCS) Telehealth Study start?

Reducing Tobacco Smoking: a Transcranial Direct Current Stimulation (TDCS) Telehealth Study started on 2023-08-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑